$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2020 Form 10-K Financial Statement

#000143774921005171 Filed on March 05, 2021

Income Statement

Concept	2020	2019 Q4	2019 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$7.200M	$2.100M	$2.300M
YoY Change	-28.0%	-19.23%	-34.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00
YoY Change	-100.0%
% of Gross Profit
Operating Expenses	$7.100M	$2.100M	$2.300M
YoY Change	-29.0%	-19.23%	-34.29%
Operating Profit	-$9.466M	-$2.060M	-$2.262M
YoY Change	-5.17%	-21.31%	-35.67%
Interest Expense	-$9.200M	-$900.0K	-$9.000M
YoY Change	-116.64%	-93.48%	-124.52%
% of Operating Profit
Other Income/Expense, Net	-$7.708M	$2.245M	$8.777M
YoY Change	-162.9%	-1263.21%	-914.19%
Pretax Income	-$37.62M	-$698.0K	-$2.497M
YoY Change	-168.94%	-95.8%	-107.79%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$37.62M	-$698.0K	-$2.497M
YoY Change	-168.94%	-95.8%	-107.79%
Net Earnings / Revenue
Basic Earnings Per Share	-$1.81	-$0.03	-$0.12
Diluted Earnings Per Share	-$1.81	-$0.03	-$0.12
COMMON SHARES
Basic Shares Outstanding	20.75M	20.65M shares	20.66M
Diluted Shares Outstanding	20.75M		20.66M

Balance Sheet

Concept	2020	2019 Q4	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.60M	$25.00M	$45.00M
YoY Change	-37.6%	-45.3%	-35.34%
Cash & Equivalents	$15.60M	$25.03M	$45.04M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$500.0K	$1.300M	$3.300M
YoY Change	-61.54%	18.18%	57.14%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$16.10M	$26.35M	$48.33M
YoY Change	-39.02%	-43.62%	-33.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.800M	$2.101M	$2.174M
YoY Change	-14.29%	160.02%	68.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$50.40M	$34.54M	$35.26M
YoY Change	-34.63%	-46.44%	-50.81%
Other Assets	$800.0K	$1.997M	$702.0K
YoY Change	-60.0%	-23.46%	122.15%
Total Long-Term Assets	$52.90M	$81.23M	$82.52M
YoY Change	-34.85%	-17.95%	-21.64%
TOTAL ASSETS
Total Short-Term Assets	$16.10M	$26.35M	$48.33M
Total Long-Term Assets	$52.90M	$81.23M	$82.52M
Total Assets	$69.00M	$107.6M	$130.8M
YoY Change	-35.87%	-26.18%	-26.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$100.0K	$39.00K	$117.0K
YoY Change		-76.36%	588.24%
Accrued Expenses	$3.400M	$627.0K	$1.138M
YoY Change	41.67%	-71.26%	-48.58%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$3.500M	$2.429M	$3.708M
YoY Change	45.83%	-92.63%	-86.92%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$2.700M	$1.027M	$1.728M
YoY Change	-20.59%	-63.37%	-44.37%
Total Long-Term Liabilities	$2.700M	$1.027M	$1.728M
YoY Change	-20.59%	-63.37%	-44.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.500M	$2.429M	$3.708M
Total Long-Term Liabilities	$2.700M	$1.027M	$1.728M
Total Liabilities	$6.200M	$5.836M	$7.912M
YoY Change	6.9%	-92.59%	-91.66%
SHAREHOLDERS EQUITY
Retained Earnings		-$697.2M	-$675.8M
YoY Change		-4.63%	-5.41%
Common Stock		$813.0M	$812.8M
YoY Change		-0.01%	-0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$14.02M	$14.00M
YoY Change		-6.51%	-8.41%
Treasury Stock Shares		$930.0K	928.0K shares
Shareholders Equity	$62.90M	$101.7M	$122.9M
YoY Change
Total Liabilities & Shareholders Equity	$69.00M	$107.6M	$130.8M
YoY Change	-35.87%	-26.18%	-26.63%

Cashflow Statement

Concept	2020	2019 Q4	2019 Q3
OPERATING ACTIVITIES
Net Income	-$37.62M	-$698.0K	-$2.497M
YoY Change	-168.94%	-95.8%	-107.79%
Depreciation, Depletion And Amortization	$0.00
YoY Change	-100.0%
Cash From Operating Activities	-$8.143M	-$1.500M	-$6.300M
YoY Change	-59.22%	-79.73%	26.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.300M	$1.600M	$23.00M
YoY Change	-101.03%	-112.8%	-2.54%
Cash From Investing Activities	-$1.269M	$1.600M	$23.00M
YoY Change	-101.0%	-112.8%	-2.54%
FINANCING ACTIVITIES
Cash Dividend Paid	$0.00
YoY Change	-100.0%
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$40.00K	-20.70M	-44.60M
YoY Change	-99.96%	25.45%
NET CHANGE
Cash From Operating Activities	-$8.143M	-1.500M	-6.300M
Cash From Investing Activities	-$1.269M	1.600M	23.00M
Cash From Financing Activities	-$40.00K	-20.70M	-44.60M
Net Change In Cash	-$9.452M	-20.60M	-27.90M
YoY Change	-156.09%	-43.41%	-250.0%
FREE CASH FLOW
Cash From Operating Activities	-$8.143M	-$1.500M	-$6.300M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20944305
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	688000
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	930000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	500000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	USD
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2019	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2018Q1	sfe	Preferred Stock Purchase Right To Be Exchanged For Common Stock Above Maximum Ownership Threshold PreferredStockPurchaseRightToBeExchangedForCommonStockAboveMaximumOwnershipThreshold	1
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2019	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0.0	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2019	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	0.0	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15601000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25028000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	462000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1297000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	16063000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	26350000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1790000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2101000	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	50398000	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	77129000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	784000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1997000	USD
CY2020Q4	us-gaap	Assets Assets	69035000	USD
CY2019Q4	us-gaap	Assets Assets	107577000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	56000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	39000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2677000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1364000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	410000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	627000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	327000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	399000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3470000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2429000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	637000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1027000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2053000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2380000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	6160000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	5836000	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	807582000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	810856000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10200000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	14024000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-736639000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-697223000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	62875000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	101741000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69035000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	107577000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9466000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9982000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-9466000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-9982000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7708000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12255000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	261000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	2044000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	-0	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	14023000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-20702000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	64267000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37615000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	54561000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-37615000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	54561000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.81
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.64
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.81
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.64
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20751000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20636000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20751000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20636000
CY2020	us-gaap	Profit Loss ProfitLoss	-37615000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	54561000	USD
CY2020	sfe	Other Comprehensive Income Loss Share Of Other Comprehensive Income Loss Of Equity Method Investments OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments	0	USD
CY2019	sfe	Other Comprehensive Income Loss Share Of Other Comprehensive Income Loss Of Equity Method Investments OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments	-31000	USD
CY2020	sfe	Other Comprehensive Income Loss Reclassification Adjustment On Sale Of Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentOnSaleOfEquityMethodInvestments	0	USD
CY2019	sfe	Other Comprehensive Income Loss Reclassification Adjustment On Sale Of Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentOnSaleOfEquityMethodInvestments	6000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-37615000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	54536000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	66979000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	54561000	USD
CY2019	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-236000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1141000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-25000	USD
CY2019	us-gaap	Dividends Dividends	20679000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	101741000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-37615000	USD
CY2020	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-40000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	590000	USD
CY2020	sfe	Cumulative Effect Of Change In Accounting At Ownership Interests CumulativeEffectOfChangeInAccountingAtOwnershipInterests	-1801000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	62875000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-37615000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	54561000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	808000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3454000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	311000	USD
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	260000	USD
CY2020	sfe	Income Loss From Equity Method Investments Excluding Impairments IncomeLossFromEquityMethodInvestmentsExcludingImpairments	-9420000	USD
CY2019	sfe	Income Loss From Equity Method Investments Excluding Impairments IncomeLossFromEquityMethodInvestmentsExcludingImpairments	67232000	USD
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-20039000	USD
CY2019	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3012000	USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-0	USD
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	5060000	USD
CY2020	sfe	Gain Loss From Observable Price Changes GainLossFromObservablePriceChanges	1224000	USD
CY2019	sfe	Gain Loss From Observable Price Changes GainLossFromObservablePriceChanges	4526000	USD
CY2020	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-175000	USD
CY2019	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	2315000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	965000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1237000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	137000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	823000	USD
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-77000	USD
CY2019	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-3346000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8143000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19970000	USD
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	7534000	USD
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	11640000	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	7903000	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	104302000	USD
CY2020	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	1638000	USD
CY2019	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	5055000	USD
CY2020	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	0	USD
CY2019	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	750000	USD
CY2020	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	-0	USD
CY2019	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	57243000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	95189000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1269000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	126303000	USD
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	-0	USD
CY2019	us-gaap	Payments Of Dividends PaymentsOfDividends	20679000	USD
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	-0	USD
CY2019	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	68568000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	40000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	236000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-89483000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-9452000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	16850000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25053000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8203000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15601000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25053000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15600000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15601000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25028000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	25000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15601000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Accounting Estimates</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results <em style="font: inherit;"> may </em>differ from these estimates. These estimates include the evaluation of the recoverability of the Company’s ownership interests and advances, the recoverability of deferred tax assets, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Certain amounts recorded to reflect the Company’s share of income or losses for companies accounted for under the equity method are based on unaudited results of operations of those companies and <em style="font: inherit;"> may </em>require adjustments in the future when audits of these entities’ financial statements are completed.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">It is reasonably possible that the Company’s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company’s ownership interests and advances could change in the near term and that the effect of such changes on the consolidated financial statements could be material. At <em style="font: inherit;"> December 31, 2020</em>, the Company believes the carrying value of the Company’s ownership interests and advances is <em style="font: inherit;">not</em> impaired, although there can be <em style="font: inherit;">no</em> assurance that the Company’s future results will confirm this assessment, that a significant write-down or write-off will <em style="font: inherit;">not</em> be required in the future or that a significant loss will <em style="font: inherit;">not</em> be recorded in the future upon the sale of a company.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p>
CY2020Q4	sfe	Lessor Operating Lease Payment To Be Received After Year Six LessorOperatingLeasePaymentToBeReceivedAfterYearSix	0	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25053000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.12	pure
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	500000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	USD
CY2019Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P18M
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	595000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	525000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	601000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	540000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	607000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	556000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	613000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	573000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	619000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	590000	USD
CY2020Q4	sfe	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	208000	USD
CY2020Q4	sfe	Lessor Operating Lease Payments To Be Received Six Years LessorOperatingLeasePaymentsToBeReceivedSixYears	199000	USD
CY2020Q4	sfe	Lessee Operating Lease Liability To Be Paid After Year Six LesseeOperatingLeaseLiabilityToBePaidAfterYearSix	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3243000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	2983000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	863000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2380000	USD
CY2020Q4	sfe	Net Operating Loss Carryforwards Expiring In Year One NetOperatingLossCarryforwardsExpiringInYearOne	3728000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	27821000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	34542000	USD
CY2020Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	19951000	USD
CY2019Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	27484000	USD
CY2020Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	2626000	USD
CY2019Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	15103000	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	50398000	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	77129000	USD
CY2019	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	4500000	USD
CY2020Q4	sfe	Equity Method Investment Assets Exceed Carrying Value Of Investment EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment	17900000	USD
CY2019Q4	sfe	Debt Instrument Gain Loss From Covenant Liability DebtInstrumentGainLossFromCovenantLiability	5100000	USD
CY2015Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000.0	USD
CY2018Q1	sfe	Sale Of Stock Individual Ownership Percent Maximum SaleOfStockIndividualOwnershipPercentMaximum	0.0499	pure
CY2019Q4	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1.00
CY2019Q4	us-gaap	Dividends Dividends	20700000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	965000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1237000	USD
CY2020Q4	sfe	Sharebased Compensation Arrangement By Sharebased Payment Award Number Of Award Vesting Types SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfAwardVestingTypes	2	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2020Q4	sfe	Cash Liability For Performancebased Units CashLiabilityForPerformancebasedUnits	0.0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	112215000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1	pure
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.05	pure
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000	USD
CY2020	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0.0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.041	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.169	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.214	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2020Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	38361000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	32760000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	76023000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	70914000	USD
CY2020Q4	sfe	Deferred Tax Asset Disallowed Interest Carryforwards DeferredTaxAssetDisallowedInterestCarryforwards	7292000	USD
CY2019Q4	sfe	Deferred Tax Asset Disallowed Interest Carryforwards DeferredTaxAssetDisallowedInterestCarryforwards	7292000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	497000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	213000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	302000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	432000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	482000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	604000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	122957000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	112215000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	122957000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	362000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	37000000	USD
CY2020Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Two NetOperatingLossCarryforwardsExpiringInYearTwo	48848000	USD
CY2020Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Three NetOperatingLossCarryforwardsExpiringInYearThree	52512000	USD
CY2020Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Four NetOperatingLossCarryforwardsExpiringInYearFour	50140000	USD
CY2020Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Five And Thereafter NetOperatingLossCarryforwardsExpiringInYearFiveAndThereafter	170189000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	325417000	USD
CY2020	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-37615000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	54561000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20751000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20636000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.81
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.64
CY2020	us-gaap	Profit Loss ProfitLoss	-37615000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	54561000	USD
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20751000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20636000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.81
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.64
CY2001Q4	sfe	Future Annual Payment To Chairman And Chief Executive Officer FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer	650000	USD
CY2001Q4	sfe	Deferred Compensation Arrangement With Individual Gain Loss DeferredCompensationArrangementWithIndividualGainLoss	1700000	USD
CY2020Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	1800000	USD
CY2020Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	1500000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7353000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-16008000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-9911000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-4343000	USD
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	6800000	USD
CY2019	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2300000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	0.0	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	11500000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	0.0	USD
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2020Q4	sfe	Partner Companies Not Consolidated In Financial Statements PartnerCompaniesNotConsolidatedInFinancialStatements	12	pure
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3532000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2028000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2275000	USD
CY2020Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1631000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3532000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2028000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2275000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1631000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3567000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2658000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-820000	USD
CY2020Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-663000	USD
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	105000	USD
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	52000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	52000	USD
CY2020Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	52000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9014000	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5277000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1300000	USD
CY2020Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5111000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16008000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9911000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4343000	USD
CY2020Q4	us-gaap	Profit Loss ProfitLoss	-7353000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.77
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.77
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3057000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2603000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2262000	USD
CY2019Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2060000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3057000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2603000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2262000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2060000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1885000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3118000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8777000	USD
CY2019Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2245000	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	873000	USD
CY2019Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	763000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	234000	USD
CY2019Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	174000	USD
CY2019Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2535000	USD
CY2019Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	5682000	USD
CY2019Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	5806000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	28267000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	40497000	USD
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3440000	USD
CY2019Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1057000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21663000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	36093000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2497000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-698000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	21663000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	36093000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2497000	USD
CY2019Q4	us-gaap	Profit Loss ProfitLoss	-698000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.75
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.75
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03

Files In Submission

Name	View Source	Status
0001437749-21-005171-index-headers.html	Edgar Link	pending
0001437749-21-005171-index.html	Edgar Link	pending
0001437749-21-005171.txt	Edgar Link	pending
0001437749-21-005171-xbrl.zip	Edgar Link	pending
ex_208595.htm	Edgar Link	pending
ex_208596.htm	Edgar Link	pending
ex_208597.htm	Edgar Link	pending
ex_208598.htm	Edgar Link	pending
ex_208599.htm	Edgar Link	pending
ex_208600.htm	Edgar Link	pending
ex_231366.htm	Edgar Link	pending
ex_231367.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20201231.xsd	Edgar Link	pending
sfe-20201231_cal.xml	Edgar Link	unprocessable
sfe-20201231_def.xml	Edgar Link	unprocessable
sfe-20201231_lab.xml	Edgar Link	unprocessable
sfe-20201231_pre.xml	Edgar Link	unprocessable
sfe20201231_10k.htm	Edgar Link	pending
sfe20201231_10k_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2020 Form 10-K Financial Statement

#000143774921005171 Filed on March 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2020 Form 10-K Financial Statement

#000143774921005171 Filed on March 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes